WA-VIRTUOZZO
13.10.2021 13:02:12 CEST | Business Wire | Press release
Virtuozzo , a global leader in high-efficiency virtualization and hyperconverged software solutions, today announced its collaboration with DT Technology Group has accelerated DT’s transition from a leading telco to a leading digital platform enabler. Through the use of Virtuozzo Hybrid Infrastructure , DT has deployed a Public Cloud as well as new revenue streams via DevOps services—all while reducing its total cost of ownership by 30 percent.
Increasingly, companies seek to leverage digital solutions to transform their businesses. Simultaneously, SmartCity projects show no signs of slowing down. However, the continued growth of 5G connectivity and IoT applications brings with it new infrastructure design challenges—integration of AI computing, Cloud Native applications, GPU computing, application modernization, and DevOps resources. The supporting network infrastructure must be robust enough to scale with the demand while the software development ecosystem around it must be mature enough to enable enterprises as well as small- to medium-sized companies to leverage the technology trends for business gain.
Drawing on its ICT system integration and telecom roots, DT sought to address both needs by building an enterprise-grade and 5G-ready infrastructure as well as establishing a team of skilled digital software developers. In the late 2010’s, the company launched its Cloud platform and digital software solutions suite via partnerships with a hyperscaler and proprietary virtualization solutions provider, though quickly sought to replace them… and did with a single partner: Virtuozzo.
“We have a unique market opportunity. We understand the infrastructure requirements behind carrier grade platforms and are leveraging this expertise to build seamless, elastic enterprise-grade digital platforms,” said Tolga Dinçer, CEO, DT Technology Group. “Our initial partner choices, however, limited what we could deliver to customers as they were complicated to use, inflexible, and quite expensive. Virtuozzo Hybrid Infrastructure solved all of those problems out of the box.”
A Public Cloud for Modern Times
DT uses the OpenStack-based Virtuozzo Hybrid Infrastructure to host a robust 5G-enabled infrastructure supporting Public Cloud, Edge data centers, and OnPrem needs. The Cloud infrastructure scales easily and notably taps into local data centers to satisfy data sovereignty requirements. Further, its inherent capabilities driven by Virtuozzo’s hyperconverged system include support for various advanced solutions—from graphics-rich VDI services to compute-heavy, AI-dependent big data analytics.
A Digital Platform Partner for the DevOps Community
To help businesses capitalize on its robust infrastructure, DT also uses Virtuozzo’s software to deliver digital solutions. This offering includes consultative services as well as digital platform development—such as microservices architecture design—for cross-industry customers, and depends heavily on Virtuozzo Hybrid Infrastructure’s core features:
- Security and business continuity
- Production-ready Kubernetes environment and tools
- Flexible licensing models (PAYG pricing)
- Immediate scalability, up or down
- Storge-as-a-Service
- Hardware vendor agnostic
“Virtuozzo is purpose-built to help companies like DT shift their and their customers’ business models from capex to opex, helping reduce costs while gaining the benefits of hyperconverged, Cloud-driven digital transformation,” said Alex Fine, Virtuozzo CEO. “We’re seeing increased adoption of our technology by savvy service providers striving to deliver alternative Cloud services: services that compete with those of hyperscalers in diversity, performance and capabilities, but are simpler, more flexible, and far more cost-efficient to use. To that end, DT is optimizing Virtuozzo Hybrid Infrastructure to an incredible extent. We’re excited to see what they’ve accomplished to date and are proud to be a part of their continued journey.”
About DT Technology Group
Headquartered in Istanbul, DT Technology Group (www.dt.net.tr ) is an international digital platform enabler servicing Turkey and other locations worldwide. Since its 2006 inception, DT has evolved from being an ICT systems integrator to a telco responsible for thousands of installations of carrier network infrastructure for 2G through to 5G networks. In 2018, the company packaged its experience to create an enterprise-grade, 5G-ready multiregional Public Cloud offering.
About Virtuozzo
Virtuozzo (www.virtuozzo.com ) is a leading, global provider of hybrid virtualization, storage, and cloud enablement software solutions. The Company's software-defined, hyperconverged self-service platform and resource management capabilities enable hosting and service providers to provide end-customers with public and private cloud services. Virtuozzo is an industry pioneer who developed the first commercially available container technology 21 years ago. The Company provides software solutions and services to over 750 service providers, ISVs, and enterprises worldwide to enable hundreds of thousands of virtual environments, running mission-critical cloud workloads. A significant force in the open-source community, Virtuozzo sponsors and/or is a contributor to numerous open-source projects including KVM, Docker, OpenStack, OpenVZ, CRIU, and the Linux kernel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211013005219/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
